> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Jubilant Cadista Recalls 1 Contraceptive Lot
- URL: https://www.fdaweb.com/jubilant-cadista-recalls-1-contraceptive-lot/
- Published: 2019-07-24T12:00:00.000Z
- Updated: 2026-09-15T01:39:49.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144609

Jubilant Cadista Pharmaceuticals (Salisbury, MD) has recalled one lot of drospirenone and ethinyl estradiol tablets due to out-of-specification dissolution results at the three-month stability time point. The affected product is made by contract manufacturer Cyndea Pharma in Soria, Spain. As a result of the dissolution results, product efficacy may be decreased due to incomplete absorption of the active ingredients, a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/jubilant-cadista-pharmaceuticals-inc-issues-voluntary-nationwide-recall-drospirenone-and-ethinyl?utm%5Fcampaign=Jubilant%20Cadista%20Pharmaceuticals%20Inc.%20Issues%20Voluntary%20Nationwide%20Recall%20of%20Drospirenone%20and%20Ethinyl&utm%5Fmedium=email&utm%5Fsource=Eloqua) says. To date, Jubilant says it has not received any reports of adverse events related to the recall. Drospirenone and Ethinyl Estradiol tablets are an estrogen/progestin combination oral contraceptive.